• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】25337

【品名】(1S,2S,3R,4S,7R,9S,10R,12R,15S)-4,12-bis(acetoxy)-9-[[(E)-3-(3-benzoylphenyl)-2-propenoyl]oxy]-15-([(2R,3S)-3-[(tert-butoxycarbonyl)amino]-3-phenyl-2-[(triisopropylsilyl)oxy]propanoyl]oxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[1

【CA登记号】

【 分 子 式 】C70H85NO17Si

【 分 子 量 】1240.52694

【元素组成】C 67.78% H 6.91% N 1.13% O 21.93% Si 2.26%

与该中间体有关的原料药合成路线共 3 条

合成路线1

该中间体在本合成路线中的序号:(VII)

Selective protection of the 7-hydroxyl group of deacetylbaccatin (I) with triethylsilyl chloride provided silyl ether (II), which was acetylated at position 10 using acetyl chloride and lithium hexamethyldisilazide. Further coupling of (II) with beta-lactam (III) gave (IV), which by selective removal of the 7-silyl group with 0.1 N HCl gave 10-acetyl-2'-(triisopropylsilyl)docetaxel (V). This was condensed with benzoylcinnamic acid (VI) employing EDC and DMAP to afford ester (VII).

1 Ahern, D.G.; Ojima, I.; Bounaud, P.-Y.; New photoaffinity analogs of paclitaxel. Bioorg Med Chem Lett 1999, 9, 8, 1189.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 25331 3-hydroxyacetophenone; 1-(3-hydroxyphenyl)-1-ethanone 121-71-1 C8H8O2 详情 详情
(II) 25332 (E)-3-(3,4-dimethoxyphenyl)-1-(3-hydroxyphenyl)-2-propen-1-one C17H16O4 详情 详情
(III) 25333 tert-butyl (3R,4S)-2-oxo-4-phenyl-3-[(triisopropylsilyl)oxy]-1-azetidinecarboxylate C23H37NO4Si 详情 详情
(IV) 25334 (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-([(2R,3S)-3-[(tert-butoxycarbonyl)amino]-3-phenyl-2-[(triisopropylsilyl)oxy]propanoyl]oxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]h C60H89NO15Si2 详情 详情
(V) 25335 (1S,2S,3R,4S,7R,9S,10R,12R,15S)-4,12-bis(acetoxy)-15-([(2R,3S)-3-[(tert-butoxycarbonyl)amino]-3-phenyl-2-[(triisopropylsilyl)oxy]propanoyl]oxy)-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl C54H75NO15Si 详情 详情
(VI) 25336 (E)-3-(3-benzoylphenyl)-2-propenoic acid C16H12O3 详情 详情
(VII) 25337 (1S,2S,3R,4S,7R,9S,10R,12R,15S)-4,12-bis(acetoxy)-9-[[(E)-3-(3-benzoylphenyl)-2-propenoyl]oxy]-15-([(2R,3S)-3-[(tert-butoxycarbonyl)amino]-3-phenyl-2-[(triisopropylsilyl)oxy]propanoyl]oxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[1 C70H85NO17Si 详情 详情

合成路线2

该中间体在本合成路线中的序号:(VII)

The triisopropylsilyl group at position 2' of (VII) was deprotected with HF in pyridine-acetonitrile yielding (VIII), and the Boc group was further removed with trifluoroacetic acid to give (IX). Then, benzoylation of the 3'-amino group of (IX) with benzoyl chloride provided benzamide (X). Finally, hydrogenation of the cinnamyl double bond of (X) in the presence of Wilkinson's catalyst furnished the target compound.

1 Ahern, D.G.; Ojima, I.; Bounaud, P.-Y.; New photoaffinity analogs of paclitaxel. Bioorg Med Chem Lett 1999, 9, 8, 1189.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VII) 25337 (1S,2S,3R,4S,7R,9S,10R,12R,15S)-4,12-bis(acetoxy)-9-[[(E)-3-(3-benzoylphenyl)-2-propenoyl]oxy]-15-([(2R,3S)-3-[(tert-butoxycarbonyl)amino]-3-phenyl-2-[(triisopropylsilyl)oxy]propanoyl]oxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[1 C70H85NO17Si 详情 详情
(VIII) 25338 (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-9-[[(E)-3-(3-benzoylphenyl)-2-propenoyl]oxy]-15-([(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl]oxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4 C61H65NO17 详情 详情
(IX) 25339 (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-amino-2-hydroxy-3-phenylpropanoyl]oxy]-9-[[(E)-3-(3-benzoylphenyl)-2-propenoyl]oxy]-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl C56H57NO15 详情 详情
(X) 25340 (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy]-9-[[(E)-3-(3-benzoylphenyl)-2-propenoyl]oxy]-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate C63H61NO16 详情 详情

合成路线3

该中间体在本合成路线中的序号:(II)

(S)-Pipecolinic acid (I) was protected as the Fmoc-derivative (II) using 9-fluorenylmethyl chloroformate and Na2CO3. Subsequent coupling of (II) with O-(tert-butyldiphenylsilyl)hydroxylamine (III) by means of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) provided the silyl hydroxamate (IV). Removal of the Fmoc group of (IV) was then achieved by treatment with diethylamine in THF to provide (V). Treatment of 4-[4-(imidazol-1-yl)phenoxy]piperidine (VI) with chlorosulfonic acid and then with phosphorus pentachloride afforded the sulfamyl chloride (VII). This was coupled with piperidine (V) in the presence of Et3N to yield the sulfamide derivative (VIII). Finally, removal of the silyl protecting group of (VIII) was carried out with tetrabutylammonium fluoride in CH2Cl2.

1 Mitchell, L.J. Jr.; Burke, B.; Dagostino, E.; et al.; Novel sulfamides and sulfonamide inhibitors of matrix metalloproteases. 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst MEDI 76.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 17380 (2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid 3105-95-1 C6H11NO2 详情 详情
(II) 25337 (1S,2S,3R,4S,7R,9S,10R,12R,15S)-4,12-bis(acetoxy)-9-[[(E)-3-(3-benzoylphenyl)-2-propenoyl]oxy]-15-([(2R,3S)-3-[(tert-butoxycarbonyl)amino]-3-phenyl-2-[(triisopropylsilyl)oxy]propanoyl]oxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[1 C70H85NO17Si 详情 详情
(III) 33013 O-[tert-butyl(diphenyl)silyl]hydroxylamine; (aminooxy)(tert-butyl)diphenylsilane C16H21NOSi 详情 详情
(IV) 33009 9H-fluoren-9-ylmethyl (2R)-2-[([[tert-butyl(diphenyl)silyl]oxy]amino)carbonyl]-1-piperidinecarboxylate C37H40N2O4Si 详情 详情
(V) 33010 (2R)-N-[[tert-butyl(diphenyl)silyl]oxy]-2-piperidinecarboxamide C22H30N2O2Si 详情 详情
(VI) 33014 4-[4-(1H-imidazol-1-yl)phenoxy]piperidine; 4-(1H-imidazol-1-yl)phenyl 4-piperidinyl ether C14H17N3O 详情 详情
(VII) 33015 4-[4-(1H-imidazol-1-yl)phenoxy]-1-piperidinesulfonyl chloride C14H16ClN3O3S 详情 详情
(VIII) 33016 (2R)-N-[[tert-butyl(diphenyl)silyl]oxy]-1-([4-[4-(1H-imidazol-1-yl)phenoxy]-1-piperidinyl]sulfonyl)-2-piperidinecarboxamide C36H45N5O5SSi 详情 详情
Extended Information